nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—skeletal joint—systemic scleroderma	0.0268	0.204	CbGeAlD
Salicylate-sodium—PTGS1—artery—systemic scleroderma	0.0117	0.0894	CbGeAlD
Salicylate-sodium—PTGS2—artery—systemic scleroderma	0.0112	0.0854	CbGeAlD
Salicylate-sodium—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.0101	0.624	CbGdCrCtD
Salicylate-sodium—PTGS1—endothelium—systemic scleroderma	0.00992	0.0755	CbGeAlD
Salicylate-sodium—PTGS2—endothelium—systemic scleroderma	0.00948	0.0722	CbGeAlD
Salicylate-sodium—PTGS1—blood vessel—systemic scleroderma	0.00915	0.0696	CbGeAlD
Salicylate-sodium—PTGS2—blood vessel—systemic scleroderma	0.00875	0.0665	CbGeAlD
Salicylate-sodium—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00612	0.376	CbGdCrCtD
Salicylate-sodium—PTGS1—connective tissue—systemic scleroderma	0.00469	0.0357	CbGeAlD
Salicylate-sodium—PTGS2—connective tissue—systemic scleroderma	0.00448	0.0341	CbGeAlD
Salicylate-sodium—PTGS1—smooth muscle tissue—systemic scleroderma	0.00429	0.0326	CbGeAlD
Salicylate-sodium—PTGS1—skin of body—systemic scleroderma	0.00424	0.0322	CbGeAlD
Salicylate-sodium—PTGS2—smooth muscle tissue—systemic scleroderma	0.0041	0.0312	CbGeAlD
Salicylate-sodium—PTGS2—skin of body—systemic scleroderma	0.00405	0.0308	CbGeAlD
Salicylate-sodium—PTGS1—digestive system—systemic scleroderma	0.00339	0.0258	CbGeAlD
Salicylate-sodium—PTGS2—digestive system—systemic scleroderma	0.00324	0.0246	CbGeAlD
Salicylate-sodium—PTGS1—tendon—systemic scleroderma	0.00322	0.0245	CbGeAlD
Salicylate-sodium—PTGS2—tendon—systemic scleroderma	0.00308	0.0234	CbGeAlD
Salicylate-sodium—PTGS1—lung—systemic scleroderma	0.00283	0.0215	CbGeAlD
Salicylate-sodium—PTGS2—lung—systemic scleroderma	0.00271	0.0206	CbGeAlD
Salicylate-sodium—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00125	CcSEcCtD
Salicylate-sodium—Pruritus—Mometasone—systemic scleroderma	0.00105	0.00124	CcSEcCtD
Salicylate-sodium—Tachycardia—Leflunomide—systemic scleroderma	0.00105	0.00124	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00104	0.00122	CcSEcCtD
Salicylate-sodium—Confusional state—Mycophenolic acid—systemic scleroderma	0.00104	0.00122	CcSEcCtD
Salicylate-sodium—Abdominal pain—Captopril—systemic scleroderma	0.00103	0.00121	CcSEcCtD
Salicylate-sodium—Body temperature increased—Captopril—systemic scleroderma	0.00103	0.00121	CcSEcCtD
Salicylate-sodium—Oedema—Mycophenolic acid—systemic scleroderma	0.00103	0.00121	CcSEcCtD
Salicylate-sodium—Anorexia—Leflunomide—systemic scleroderma	0.00103	0.00121	CcSEcCtD
Salicylate-sodium—Nausea—Pentoxifylline—systemic scleroderma	0.00103	0.0012	CcSEcCtD
Salicylate-sodium—Infection—Mycophenolic acid—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Salicylate-sodium—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Salicylate-sodium—Diarrhoea—Mometasone—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Prednisone—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Salicylate-sodium—Syncope—Lisinopril—systemic scleroderma	0.00102	0.0012	CcSEcCtD
Salicylate-sodium—Renal failure acute—Methotrexate—systemic scleroderma	0.00101	0.00119	CcSEcCtD
Salicylate-sodium—Shock—Mycophenolic acid—systemic scleroderma	0.00101	0.00119	CcSEcCtD
Salicylate-sodium—Hypotension—Leflunomide—systemic scleroderma	0.00101	0.00118	CcSEcCtD
Salicylate-sodium—Tachycardia—Mycophenolic acid—systemic scleroderma	0.001	0.00118	CcSEcCtD
Salicylate-sodium—Palpitations—Lisinopril—systemic scleroderma	0.001	0.00118	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Lisinopril—systemic scleroderma	0.000999	0.00117	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000995	0.00117	CcSEcCtD
Salicylate-sodium—Anorexia—Mycophenolic acid—systemic scleroderma	0.000981	0.00115	CcSEcCtD
Salicylate-sodium—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000981	0.00115	CcSEcCtD
Salicylate-sodium—Abdominal distension—Prednisone—systemic scleroderma	0.000975	0.00114	CcSEcCtD
Salicylate-sodium—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000975	0.00114	CcSEcCtD
Salicylate-sodium—Paraesthesia—Leflunomide—systemic scleroderma	0.000969	0.00114	CcSEcCtD
Salicylate-sodium—Chest pain—Lisinopril—systemic scleroderma	0.000967	0.00113	CcSEcCtD
Salicylate-sodium—Anxiety—Lisinopril—systemic scleroderma	0.000964	0.00113	CcSEcCtD
Salicylate-sodium—Dyspnoea—Leflunomide—systemic scleroderma	0.000962	0.00113	CcSEcCtD
Salicylate-sodium—Hypotension—Mycophenolic acid—systemic scleroderma	0.000962	0.00113	CcSEcCtD
Salicylate-sodium—Lethargy—Methotrexate—systemic scleroderma	0.000956	0.00112	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000956	0.00112	CcSEcCtD
Salicylate-sodium—Dyspepsia—Leflunomide—systemic scleroderma	0.00095	0.00111	CcSEcCtD
Salicylate-sodium—Vomiting—Mometasone—systemic scleroderma	0.000948	0.00111	CcSEcCtD
Salicylate-sodium—Sweating increased—Prednisone—systemic scleroderma	0.000943	0.00111	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Azathioprine—systemic scleroderma	0.000942	0.0011	CcSEcCtD
Salicylate-sodium—Rash—Mometasone—systemic scleroderma	0.00094	0.0011	CcSEcCtD
Salicylate-sodium—Asthenia—Captopril—systemic scleroderma	0.000939	0.0011	CcSEcCtD
Salicylate-sodium—Dermatitis—Mometasone—systemic scleroderma	0.000939	0.0011	CcSEcCtD
Salicylate-sodium—Decreased appetite—Leflunomide—systemic scleroderma	0.000938	0.0011	CcSEcCtD
Salicylate-sodium—Confusional state—Lisinopril—systemic scleroderma	0.000935	0.0011	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000934	0.0011	CcSEcCtD
Salicylate-sodium—Headache—Mometasone—systemic scleroderma	0.000934	0.0011	CcSEcCtD
Salicylate-sodium—Fatigue—Leflunomide—systemic scleroderma	0.00093	0.00109	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000927	0.00109	CcSEcCtD
Salicylate-sodium—Oedema—Lisinopril—systemic scleroderma	0.000927	0.00109	CcSEcCtD
Salicylate-sodium—Pruritus—Captopril—systemic scleroderma	0.000926	0.00109	CcSEcCtD
Salicylate-sodium—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000924	0.00108	CcSEcCtD
Salicylate-sodium—Constipation—Leflunomide—systemic scleroderma	0.000923	0.00108	CcSEcCtD
Salicylate-sodium—Pain—Leflunomide—systemic scleroderma	0.000923	0.00108	CcSEcCtD
Salicylate-sodium—Infection—Lisinopril—systemic scleroderma	0.000921	0.00108	CcSEcCtD
Salicylate-sodium—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000918	0.00108	CcSEcCtD
Salicylate-sodium—Somnolence—Mycophenolic acid—systemic scleroderma	0.000915	0.00107	CcSEcCtD
Salicylate-sodium—Shock—Lisinopril—systemic scleroderma	0.000912	0.00107	CcSEcCtD
Salicylate-sodium—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000906	0.00106	CcSEcCtD
Salicylate-sodium—Tachycardia—Lisinopril—systemic scleroderma	0.000905	0.00106	CcSEcCtD
Salicylate-sodium—Abdominal pain—Azathioprine—systemic scleroderma	0.000903	0.00106	CcSEcCtD
Salicylate-sodium—Body temperature increased—Azathioprine—systemic scleroderma	0.000903	0.00106	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000896	0.00105	CcSEcCtD
Salicylate-sodium—Diarrhoea—Captopril—systemic scleroderma	0.000896	0.00105	CcSEcCtD
Salicylate-sodium—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000895	0.00105	CcSEcCtD
Salicylate-sodium—Irritability—Methotrexate—systemic scleroderma	0.000894	0.00105	CcSEcCtD
Salicylate-sodium—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00105	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Leflunomide—systemic scleroderma	0.000889	0.00104	CcSEcCtD
Salicylate-sodium—Fatigue—Mycophenolic acid—systemic scleroderma	0.000887	0.00104	CcSEcCtD
Salicylate-sodium—Nausea—Mometasone—systemic scleroderma	0.000885	0.00104	CcSEcCtD
Salicylate-sodium—Anorexia—Lisinopril—systemic scleroderma	0.000884	0.00104	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000882	0.00104	CcSEcCtD
Salicylate-sodium—Weight increased—Prednisone—systemic scleroderma	0.000881	0.00103	CcSEcCtD
Salicylate-sodium—Pain—Mycophenolic acid—systemic scleroderma	0.00088	0.00103	CcSEcCtD
Salicylate-sodium—Constipation—Mycophenolic acid—systemic scleroderma	0.00088	0.00103	CcSEcCtD
Salicylate-sodium—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00088	0.00103	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000875	0.00103	CcSEcCtD
Salicylate-sodium—Hypotension—Lisinopril—systemic scleroderma	0.000866	0.00102	CcSEcCtD
Salicylate-sodium—Dizziness—Captopril—systemic scleroderma	0.000866	0.00102	CcSEcCtD
Salicylate-sodium—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000862	0.00101	CcSEcCtD
Salicylate-sodium—Urticaria—Leflunomide—systemic scleroderma	0.000857	0.00101	CcSEcCtD
Salicylate-sodium—Abdominal pain—Leflunomide—systemic scleroderma	0.000853	0.001	CcSEcCtD
Salicylate-sodium—Body temperature increased—Leflunomide—systemic scleroderma	0.000853	0.001	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000851	0.000999	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000848	0.000995	CcSEcCtD
Salicylate-sodium—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000847	0.000994	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Prednisone—systemic scleroderma	0.000846	0.000993	CcSEcCtD
Salicylate-sodium—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000845	0.000991	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Azathioprine—systemic scleroderma	0.000842	0.000988	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000842	0.000988	CcSEcCtD
Salicylate-sodium—Paraesthesia—Lisinopril—systemic scleroderma	0.000833	0.000977	CcSEcCtD
Salicylate-sodium—Vomiting—Captopril—systemic scleroderma	0.000832	0.000977	CcSEcCtD
Salicylate-sodium—Dyspnoea—Lisinopril—systemic scleroderma	0.000827	0.00097	CcSEcCtD
Salicylate-sodium—Rash—Captopril—systemic scleroderma	0.000826	0.000969	CcSEcCtD
Salicylate-sodium—Dermatitis—Captopril—systemic scleroderma	0.000825	0.000968	CcSEcCtD
Salicylate-sodium—Somnolence—Lisinopril—systemic scleroderma	0.000824	0.000967	CcSEcCtD
Salicylate-sodium—Headache—Captopril—systemic scleroderma	0.00082	0.000962	CcSEcCtD
Salicylate-sodium—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000819	0.000961	CcSEcCtD
Salicylate-sodium—Dyspepsia—Lisinopril—systemic scleroderma	0.000816	0.000958	CcSEcCtD
Salicylate-sodium—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000814	0.000955	CcSEcCtD
Salicylate-sodium—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000814	0.000955	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000812	0.000953	CcSEcCtD
Salicylate-sodium—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000812	0.000953	CcSEcCtD
Salicylate-sodium—Asthma—Methotrexate—systemic scleroderma	0.000809	0.00095	CcSEcCtD
Salicylate-sodium—Infection—Mycophenolate mofetil—systemic scleroderma	0.000807	0.000947	CcSEcCtD
Salicylate-sodium—Decreased appetite—Lisinopril—systemic scleroderma	0.000806	0.000946	CcSEcCtD
Salicylate-sodium—Fatigue—Lisinopril—systemic scleroderma	0.000799	0.000938	CcSEcCtD
Salicylate-sodium—Shock—Mycophenolate mofetil—systemic scleroderma	0.000799	0.000938	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Leflunomide—systemic scleroderma	0.000795	0.000933	CcSEcCtD
Salicylate-sodium—Constipation—Lisinopril—systemic scleroderma	0.000793	0.00093	CcSEcCtD
Salicylate-sodium—Pain—Lisinopril—systemic scleroderma	0.000793	0.00093	CcSEcCtD
Salicylate-sodium—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000793	0.00093	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000785	0.000921	CcSEcCtD
Salicylate-sodium—Diarrhoea—Azathioprine—systemic scleroderma	0.000782	0.000917	CcSEcCtD
Salicylate-sodium—Nausea—Captopril—systemic scleroderma	0.000778	0.000912	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000776	0.00091	CcSEcCtD
Salicylate-sodium—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000774	0.000909	CcSEcCtD
Salicylate-sodium—Asthenia—Leflunomide—systemic scleroderma	0.000774	0.000908	CcSEcCtD
Salicylate-sodium—Hallucination—Prednisone—systemic scleroderma	0.000771	0.000905	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Lisinopril—systemic scleroderma	0.000764	0.000896	CcSEcCtD
Salicylate-sodium—Pruritus—Leflunomide—systemic scleroderma	0.000763	0.000896	CcSEcCtD
Salicylate-sodium—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000759	0.000891	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000758	0.00089	CcSEcCtD
Salicylate-sodium—Dizziness—Azathioprine—systemic scleroderma	0.000756	0.000887	CcSEcCtD
Salicylate-sodium—Asthenia—Mycophenolic acid—systemic scleroderma	0.000739	0.000867	CcSEcCtD
Salicylate-sodium—Diarrhoea—Leflunomide—systemic scleroderma	0.000738	0.000866	CcSEcCtD
Salicylate-sodium—Urticaria—Lisinopril—systemic scleroderma	0.000737	0.000864	CcSEcCtD
Salicylate-sodium—Abdominal pain—Lisinopril—systemic scleroderma	0.000733	0.00086	CcSEcCtD
Salicylate-sodium—Body temperature increased—Lisinopril—systemic scleroderma	0.000733	0.00086	CcSEcCtD
Salicylate-sodium—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000729	0.000856	CcSEcCtD
Salicylate-sodium—Pruritus—Mycophenolic acid—systemic scleroderma	0.000728	0.000855	CcSEcCtD
Salicylate-sodium—Vomiting—Azathioprine—systemic scleroderma	0.000726	0.000852	CcSEcCtD
Salicylate-sodium—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000724	0.00085	CcSEcCtD
Salicylate-sodium—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000722	0.000847	CcSEcCtD
Salicylate-sodium—Drowsiness—Methotrexate—systemic scleroderma	0.000722	0.000847	CcSEcCtD
Salicylate-sodium—Rash—Azathioprine—systemic scleroderma	0.00072	0.000845	CcSEcCtD
Salicylate-sodium—Dermatitis—Azathioprine—systemic scleroderma	0.00072	0.000845	CcSEcCtD
Salicylate-sodium—Headache—Azathioprine—systemic scleroderma	0.000716	0.00084	CcSEcCtD
Salicylate-sodium—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000715	0.000839	CcSEcCtD
Salicylate-sodium—Dizziness—Leflunomide—systemic scleroderma	0.000714	0.000837	CcSEcCtD
Salicylate-sodium—Renal failure—Methotrexate—systemic scleroderma	0.000709	0.000832	CcSEcCtD
Salicylate-sodium—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000706	0.000829	CcSEcCtD
Salicylate-sodium—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000704	0.000826	CcSEcCtD
Salicylate-sodium—Pain—Mycophenolate mofetil—systemic scleroderma	0.000695	0.000815	CcSEcCtD
Salicylate-sodium—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000695	0.000815	CcSEcCtD
Salicylate-sodium—Arrhythmia—Prednisone—systemic scleroderma	0.000692	0.000812	CcSEcCtD
Salicylate-sodium—Vomiting—Leflunomide—systemic scleroderma	0.000686	0.000805	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Lisinopril—systemic scleroderma	0.000683	0.000801	CcSEcCtD
Salicylate-sodium—Dizziness—Mycophenolic acid—systemic scleroderma	0.000681	0.000799	CcSEcCtD
Salicylate-sodium—Epistaxis—Methotrexate—systemic scleroderma	0.000681	0.000799	CcSEcCtD
Salicylate-sodium—Rash—Leflunomide—systemic scleroderma	0.00068	0.000798	CcSEcCtD
Salicylate-sodium—Dermatitis—Leflunomide—systemic scleroderma	0.00068	0.000798	CcSEcCtD
Salicylate-sodium—Nausea—Azathioprine—systemic scleroderma	0.000679	0.000796	CcSEcCtD
Salicylate-sodium—Headache—Leflunomide—systemic scleroderma	0.000676	0.000793	CcSEcCtD
Salicylate-sodium—Erythema—Prednisone—systemic scleroderma	0.000675	0.000792	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000669	0.000785	CcSEcCtD
Salicylate-sodium—Asthenia—Lisinopril—systemic scleroderma	0.000665	0.000781	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000664	0.000779	CcSEcCtD
Salicylate-sodium—Pruritus—Lisinopril—systemic scleroderma	0.000656	0.00077	CcSEcCtD
Salicylate-sodium—Vomiting—Mycophenolic acid—systemic scleroderma	0.000655	0.000768	CcSEcCtD
Salicylate-sodium—Rash—Mycophenolic acid—systemic scleroderma	0.000649	0.000762	CcSEcCtD
Salicylate-sodium—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000648	0.000761	CcSEcCtD
Salicylate-sodium—Hepatitis—Methotrexate—systemic scleroderma	0.000648	0.00076	CcSEcCtD
Salicylate-sodium—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000645	0.000757	CcSEcCtD
Salicylate-sodium—Headache—Mycophenolic acid—systemic scleroderma	0.000645	0.000757	CcSEcCtD
Salicylate-sodium—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000642	0.000753	CcSEcCtD
Salicylate-sodium—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000642	0.000753	CcSEcCtD
Salicylate-sodium—Nausea—Leflunomide—systemic scleroderma	0.000641	0.000752	CcSEcCtD
Salicylate-sodium—Vision blurred—Prednisone—systemic scleroderma	0.000636	0.000746	CcSEcCtD
Salicylate-sodium—Diarrhoea—Lisinopril—systemic scleroderma	0.000634	0.000744	CcSEcCtD
Salicylate-sodium—Dizziness—Lisinopril—systemic scleroderma	0.000613	0.000719	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Methotrexate—systemic scleroderma	0.000612	0.000719	CcSEcCtD
Salicylate-sodium—Nausea—Mycophenolic acid—systemic scleroderma	0.000611	0.000717	CcSEcCtD
Salicylate-sodium—Syncope—Prednisone—systemic scleroderma	0.000605	0.00071	CcSEcCtD
Salicylate-sodium—Tinnitus—Methotrexate—systemic scleroderma	0.000604	0.000709	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000599	0.000702	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Prednisone—systemic scleroderma	0.000593	0.000696	CcSEcCtD
Salicylate-sodium—Vomiting—Lisinopril—systemic scleroderma	0.00059	0.000692	CcSEcCtD
Salicylate-sodium—Rash—Lisinopril—systemic scleroderma	0.000585	0.000686	CcSEcCtD
Salicylate-sodium—Convulsion—Prednisone—systemic scleroderma	0.000585	0.000686	CcSEcCtD
Salicylate-sodium—Dermatitis—Lisinopril—systemic scleroderma	0.000584	0.000685	CcSEcCtD
Salicylate-sodium—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000583	0.000684	CcSEcCtD
Salicylate-sodium—Headache—Lisinopril—systemic scleroderma	0.000581	0.000682	CcSEcCtD
Salicylate-sodium—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000575	0.000674	CcSEcCtD
Salicylate-sodium—Anxiety—Prednisone—systemic scleroderma	0.000572	0.000672	CcSEcCtD
Salicylate-sodium—Erythema—Methotrexate—systemic scleroderma	0.000564	0.000662	CcSEcCtD
Salicylate-sodium—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000556	0.000652	CcSEcCtD
Salicylate-sodium—Dysgeusia—Methotrexate—systemic scleroderma	0.000552	0.000648	CcSEcCtD
Salicylate-sodium—Nausea—Lisinopril—systemic scleroderma	0.000551	0.000646	CcSEcCtD
Salicylate-sodium—Oedema—Prednisone—systemic scleroderma	0.000551	0.000646	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Prednisone—systemic scleroderma	0.000551	0.000646	CcSEcCtD
Salicylate-sodium—Infection—Prednisone—systemic scleroderma	0.000547	0.000642	CcSEcCtD
Salicylate-sodium—Shock—Prednisone—systemic scleroderma	0.000542	0.000636	CcSEcCtD
Salicylate-sodium—Tachycardia—Prednisone—systemic scleroderma	0.000537	0.000631	CcSEcCtD
Salicylate-sodium—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000537	0.00063	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Prednisone—systemic scleroderma	0.000532	0.000625	CcSEcCtD
Salicylate-sodium—Vision blurred—Methotrexate—systemic scleroderma	0.000531	0.000624	CcSEcCtD
Salicylate-sodium—Anorexia—Prednisone—systemic scleroderma	0.000525	0.000616	CcSEcCtD
Salicylate-sodium—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000517	0.000606	CcSEcCtD
Salicylate-sodium—Rash—Mycophenolate mofetil—systemic scleroderma	0.000512	0.000601	CcSEcCtD
Salicylate-sodium—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000512	0.0006	CcSEcCtD
Salicylate-sodium—Headache—Mycophenolate mofetil—systemic scleroderma	0.000509	0.000597	CcSEcCtD
Salicylate-sodium—Paraesthesia—Prednisone—systemic scleroderma	0.000494	0.00058	CcSEcCtD
Salicylate-sodium—Convulsion—Methotrexate—systemic scleroderma	0.000489	0.000573	CcSEcCtD
Salicylate-sodium—Dyspepsia—Prednisone—systemic scleroderma	0.000485	0.000569	CcSEcCtD
Salicylate-sodium—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000483	0.000566	CcSEcCtD
Salicylate-sodium—Chest pain—Methotrexate—systemic scleroderma	0.00048	0.000563	CcSEcCtD
Salicylate-sodium—Decreased appetite—Prednisone—systemic scleroderma	0.000479	0.000562	CcSEcCtD
Salicylate-sodium—Fatigue—Prednisone—systemic scleroderma	0.000475	0.000557	CcSEcCtD
Salicylate-sodium—Constipation—Prednisone—systemic scleroderma	0.000471	0.000553	CcSEcCtD
Salicylate-sodium—Confusional state—Methotrexate—systemic scleroderma	0.000464	0.000544	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00046	0.00054	CcSEcCtD
Salicylate-sodium—Infection—Methotrexate—systemic scleroderma	0.000457	0.000536	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Prednisone—systemic scleroderma	0.000454	0.000532	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00045	0.000528	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000445	0.000522	CcSEcCtD
Salicylate-sodium—Anorexia—Methotrexate—systemic scleroderma	0.000439	0.000515	CcSEcCtD
Salicylate-sodium—Urticaria—Prednisone—systemic scleroderma	0.000437	0.000513	CcSEcCtD
Salicylate-sodium—Body temperature increased—Prednisone—systemic scleroderma	0.000435	0.000511	CcSEcCtD
Salicylate-sodium—Abdominal pain—Prednisone—systemic scleroderma	0.000435	0.000511	CcSEcCtD
Salicylate-sodium—Hypotension—Methotrexate—systemic scleroderma	0.00043	0.000505	CcSEcCtD
Salicylate-sodium—Paraesthesia—Methotrexate—systemic scleroderma	0.000413	0.000485	CcSEcCtD
Salicylate-sodium—Dyspnoea—Methotrexate—systemic scleroderma	0.00041	0.000481	CcSEcCtD
Salicylate-sodium—Somnolence—Methotrexate—systemic scleroderma	0.000409	0.00048	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Prednisone—systemic scleroderma	0.000406	0.000476	CcSEcCtD
Salicylate-sodium—Dyspepsia—Methotrexate—systemic scleroderma	0.000405	0.000475	CcSEcCtD
Salicylate-sodium—Decreased appetite—Methotrexate—systemic scleroderma	0.0004	0.000469	CcSEcCtD
Salicylate-sodium—Fatigue—Methotrexate—systemic scleroderma	0.000397	0.000466	CcSEcCtD
Salicylate-sodium—Asthenia—Prednisone—systemic scleroderma	0.000395	0.000464	CcSEcCtD
Salicylate-sodium—Pain—Methotrexate—systemic scleroderma	0.000394	0.000462	CcSEcCtD
Salicylate-sodium—Pruritus—Prednisone—systemic scleroderma	0.00039	0.000457	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Methotrexate—systemic scleroderma	0.000379	0.000445	CcSEcCtD
Salicylate-sodium—Diarrhoea—Prednisone—systemic scleroderma	0.000377	0.000442	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000376	0.000442	CcSEcCtD
Salicylate-sodium—Urticaria—Methotrexate—systemic scleroderma	0.000366	0.000429	CcSEcCtD
Salicylate-sodium—Dizziness—Prednisone—systemic scleroderma	0.000364	0.000427	CcSEcCtD
Salicylate-sodium—Body temperature increased—Methotrexate—systemic scleroderma	0.000364	0.000427	CcSEcCtD
Salicylate-sodium—Abdominal pain—Methotrexate—systemic scleroderma	0.000364	0.000427	CcSEcCtD
Salicylate-sodium—Vomiting—Prednisone—systemic scleroderma	0.00035	0.000411	CcSEcCtD
Salicylate-sodium—Rash—Prednisone—systemic scleroderma	0.000347	0.000407	CcSEcCtD
Salicylate-sodium—Dermatitis—Prednisone—systemic scleroderma	0.000347	0.000407	CcSEcCtD
Salicylate-sodium—Headache—Prednisone—systemic scleroderma	0.000345	0.000405	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Methotrexate—systemic scleroderma	0.000339	0.000398	CcSEcCtD
Salicylate-sodium—Asthenia—Methotrexate—systemic scleroderma	0.00033	0.000387	CcSEcCtD
Salicylate-sodium—Nausea—Prednisone—systemic scleroderma	0.000327	0.000384	CcSEcCtD
Salicylate-sodium—Pruritus—Methotrexate—systemic scleroderma	0.000326	0.000382	CcSEcCtD
Salicylate-sodium—Diarrhoea—Methotrexate—systemic scleroderma	0.000315	0.000369	CcSEcCtD
Salicylate-sodium—Dizziness—Methotrexate—systemic scleroderma	0.000304	0.000357	CcSEcCtD
Salicylate-sodium—Vomiting—Methotrexate—systemic scleroderma	0.000293	0.000343	CcSEcCtD
Salicylate-sodium—Rash—Methotrexate—systemic scleroderma	0.00029	0.00034	CcSEcCtD
Salicylate-sodium—Dermatitis—Methotrexate—systemic scleroderma	0.00029	0.00034	CcSEcCtD
Salicylate-sodium—Headache—Methotrexate—systemic scleroderma	0.000288	0.000338	CcSEcCtD
Salicylate-sodium—Nausea—Methotrexate—systemic scleroderma	0.000273	0.000321	CcSEcCtD
